Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Kidney Cancer
Related studies linked through entity extraction aliases.
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast
- Status
- COMPLETED
- Phase
- PHASE1
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
- Status
- COMPLETED
- Phase
- PHASE4
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors
- Status
- WITHDRAWN
- Phase
- NA
MT2004-30: Tomotherapy for Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- N/A
Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2